Shareholders approve increase in authorized shares and warrant issuance at special meeting

Bluejay Diagnostics, Inc.

Proposal to increase authorized common stock shares passed: 223,019 for, 32,958 against, 45,001 abstain.
Proposal 2: shareholders approved issuance of Class C warrants from June 28, 2024 offering (144,962 for).
Proposal 3: shareholders approved issuance of Class D warrants from same offering (144,881 for).
Quorum achieved with 300,978 shares (53.4%) present; Proposal 4 on adjournment not acted upon.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.